Again, the findings indicate a particular susceptibility of KRAS/PIK3CA-mutant CRC entities to unfavorable responses to the combined inhibition of anti-apoptotic proteins and mTOR signaling. The gene discussed is PIK3CA; the disease is colorectal carcinoma.